Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Combination of rituximab (RTX) with several different chemotherapeutic regimes has proven
synergistic effects in patients with either lymphoma or autoimmune diseases. First data of
uncontrolled trials with the combination of RTX and leflunomide (LEF) are available.